|
FY2026
12 months to Apr 30, 2026
|
FY2025
12 months to Apr 30, 2025
|
FY2024
12 months to Apr 30, 2024
|
FY2023
12 months to Apr 30, 2023
|
FY2022
12 months to Apr 30, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Selling, marketing, and distribution | |||||
| General and administrative | |||||
| Impairment of assets held for sale | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Other income/(expense), net: | |||||
| Other income, net | |||||
| Interest (expense)/income, net | |||||
| Total other (expense)/income, net | |||||
| (Loss)/income from operations before income taxes | |||||
| Income tax expense/(benefit) | |||||
| Net loss | |||||
| Net loss per share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average number of common shares outstanding: | |||||
| Basic (in shares) | |||||
Loading...